ArticleJournal of acquired immune deficiency syndromes (1999)2026
Effects of HIV and Adverse Childhood Experiences on Neurocognition.
Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBoth HIV and adverse childhood experiences (ACEs) can affect neurocognitive performance. Among youth with perinatal HIV (PHIV), living with a chronic viral infection and experiencing ACEs simultaneously may result in an interaction between the 2 and downstream effects on neurocognition. The purpose of this study was to test the effects of PHIV, childhood adversity, and their interaction on neurocognition in a sample of South African adolescent boys.
settingSoweto, South Africa.
methodsAdolescent boys aged 15-19 years enrolled in a longitudinal study between November 2020 and June 2023. Recruitment was stratified by HIV status. At baseline, participants completed the ACE measure. Six months later they completed a battery of neurocognitive assessments ( NeuroScreen ). We created several regression models to examine the effects of HIV status, ACEs, and their interaction on neurocognition. We also built several exploratory models to probe the effects of viral suppression and various kinds of ACEs.
resultsParticipants living with PHIV scored significantly lower than those without HIV on several neurocognitive domains. Among those living with PHIV, participants with a detectable viral load during the study exhibited significantly lower performance on several domains than those who were consistently virally suppressed. We found no support for the effect of ACEs or a significant HIV*ACEs interaction on neurocognition.
conclusionsOur results underscore the importance of medication adherence and viral suppression among youth living with HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.